FDA busts Concordia on phone marketing violation; Lundbeck launches Selincro in Spain;

> A professional telephone script used by Concordia Pharmaceuticals to market its extended-released Kapvay tablets has violated the FDA's advertising regulations, the agency says. More

> Lundbeck has launched alcohol dependence med Selincro in Spain. Release

> Merck ($MRK) and the Positive Women's Network have teamed up for national HIV campaign "I Design." Story

> Quintiles ($Q) will commercialize Basilea Pharmaceutica's antibiotic Zevtera/Mabelio in Europe. Report

> Galena Biopharma has licensed the U.S. rights for oral soluble film Zuplenz. Release

> Arena Pharma ($ARNA) and Teva ($TEVA) have inked a marketing and supply deal for obesity drug Belviq in Israel. More

> Anacor Pharmaceuticals ($ANAC) and Novartis' ($NVS) Sandoz have entered a commercialization agreement for topical solution Kerydin in the United States. Release

And Finally... Eisai has launched Chocola BB Royal Drink, designed to promote beauty and wellness, in China. More

Suggested Articles

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.

While the failure might be a missed chance at revenue, it shouldn’t hurt Ibrance’s ability to rack up sales in the metastatic setting, one exec says.

One combination of Tecentriq and chemo, when used before surgery, delivered significant benefits